risedronate
information and resources from the National Cancer Institute
risedronate
A synthetic pyridinyl bisphosphonate agent. Risedronate binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption risedronate
A synthetic pyridinyl bisphosphonate agent. Risedronate binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption
|
|
|
|
news articles
Three-monthly osteoporosis drug cleared in Europe Mar 31, 2006
Pharma Times (subscription), Bisphosphonate drugs such as Bonviva, Merck & Co's Fosamax (alendronate) and Actonel (risedronate) from Procter & Gamble/Sanofi-Aventis currently represent the ...
Innovative osteoporosis treatment, FOSAVANCE(TM), integrates two ... Mar 29, 2006
CNW Telbec (Communiqués de presse), ...other commonly used anti-osteoporosis treatments through January 2005 (etidronate, ibandronate, miacalcin, pamidronate, raloxifene, risedronate, teriparatide). ...
Forecasts Tell Us That Bisphosphonates Will Remain the Mainstay of ... Mar 27, 2006
Genetic Engineering News, ...receptor modulator (SERM) raloxifene (Evista), and Procter & Gamble holds a 13% share of the market with sales of the bisphosphonate risedronate (Actonel). ...
Aclasta May Offer a New Approach for Improving Bone Health Mar 16, 2006
DG News In the extension study, 152 Aclasta patients and 115 risedronate patients were observed for a further median period of 20 months following the end of the 6 ...
Prevention of Osteoporosis Associated With Chronic Glucocorticoid ... Mar 14, 2006
Journal of American Medical Association (subscription), ...prevention and treatment of glucocorticoid-induced osteoporosis should be a potent oral bisphosphonate such as alendronate (70 mg/wk) or risedronate sodium (35 ...
Double boost for Bonviva in osteoporosis Mar 20, 2006
Pharma Times (subscription), Bisphosphonate drugs such as Bonviva, Fosamax (alendronate) and Actonel (risedronate) from Procter & Gamble/Sanofi-Aventis currently represent the gold ...
Women With Osteoporosis Prefer One Tablet Per Month, Study Shows Mar 18, 2006
Medical News Today (press release), ...et al. Influence of Patient Compliance with Risedronate Therapy on Bone Turnover Marker and Bone Mineral Density Response: The IMPACT Study. ...
Menopause and Bone Loss Mar 7, 2006
Journal of Clinical Endocrinology and Metabolism, These medications can be used in addition to calcium, vitamin D supplements and exercise: Bisphosphonates (alendronate, risedronate and ibandronate). ...
Risedronate prevents bone loss and periodontal disease Dec 7, 2005
News-Medical.net, School of Dental Medicine who reports in the current Menopause journal article, "Periodontal Assessments of Postmenopausal Women Receiving Risedronate.". ...
Postmenopause: Risedronate prevents bone loss and periodontal ... Nov 25, 2005
Xagena.it, ...risks of periodontal disease. The Risedronate group reported a higher use of vitamins and calcium supplements. Each woman received ...
High-dose Risedronate (Actonel) Appears to Delay Joint Destruction ... Nov 18, 2005
DG News SAN DIEGO, CA -- November 18, 2005 -- High doses of the osteoporosis drug risedronate (Actonel) appears to delay joint destruction, the precursor to joint ...
How the drugs giant and a lone academic went to war Dec 3, 2005
The Observer, Also known as risedronate, it has been licensed as a treatment in the UK since 2002, and is known to be safe, with a good record of reducing the risk of broken ...
|
|
